Shunsuke Aoi is a Cardiology physician affiliated with Billings Clinic. OpenAlex indexes 50 publications with 465 citations (h-index 11).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
801 N 29th St
Billings, MT 591010905
Telephone
406-238-2500Provider last certified this registry record 28 Feb 2022.
Industry payments
12 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year20259 payments
- Edwards Lifesciences CorporationProgram year20251 payment
- Boston Scientific CorporationProgram year20255 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
83.9%Beta blocker21.1%Metoprolol Succinate77%Carvedilol13%Metoprolol Tartrate6%Labetalol Hcl5%Part D<11 patientsStatin18.1%Atorvastatin Calcium65%Rosuvastatin Calcium35%Part D≥74 patients+ 9 more classes in this area
Blood & clotting
11.2%P2Y12 inhibitor5.9%Clopidogrel100%Part D≥30 patientsFactor Xa inhibitor4.5%Eliquis100%Part D≥18 patients+ 1 more class in this area
Metabolism & gastrointestinal
4.9%SGLT2 inhibitor2.4%Jardiance61%Farxiga40%Part D<11 patientsProton pump inhibitor1.7%Pantoprazole Sodium100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Comparison of interventions for intermediate to high‐risk pulmonary embolism: A network meta‐analysis
Catheterization and Cardiovascular Interventions
2023 - OCT-Defined Myocardial Bridge as a Homogenous Band: Validation With a Hybrid IVUS-OCT Catheter
Cardiovascular revascularization medicine
2022 - 869: MORTALITY AND BLEEDING RISKS OF INTERVENTIONS FOR HIGH- AND INTERMEDIATE-RISK PULMONARY EMBOLISM
Critical Care Medicine
2022
Similar KOLs
Other experts from the same institution or the same specialty.
John Schallenkamp, MD
Billings Clinic
Eugen Dolan, MD
Billings Clinic
Bradford Whitcomb, MD
Billings Clinic
Mark Piedra, MD
Billings Clinic
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”